CORGENIX LAUNCHES NEXT GENERATION PREDICTIVE CARDIOVASCULAR DIAGNOSTIC LINE

Corgenix Medical Corporation (OTCBB:CONX - News), a worldwide marketer of diagnostic test kits, announces the launch of AtherOx™, a next generation product line utilizing patented technology to identify individuals at risk for developing atherosclerotic cardiovascular disease. The AtherOx™ technology is a novel diagnostic product that measures oxidized Low-Density Lipoprotein (oxLDL) complexed with a plasma protein known as B2GP1, which combined functions as a specific marker of potential cardiovascular disease.
Yahoo News